TScan Therapeutics, Inc. (TCRX) Form 8-K — Oct 16, 2026
TScan Therapeutics announced that directors Garry Nicholson and Gabriela Gruia, M.D. resigned from the Board and all committees effective October 13, 2026. The filing states neither resignation resulted from any disagreement with the company on operations, practices, or policies. Following the resignations, the Board appointed Stephen Biggar and R.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.